These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23715217)

  • 21. Bridging from Intramuscular to Limb Perfusion Delivery of rAAV: Optimization in a Non-human Primate Study.
    Gruntman AM; Gernoux G; Tang Q; Ye GJ; Knop DR; Wang G; Benson J; Coleman KE; Keeler AM; Mueller C; Chicoine LG; Chulay JD; Flotte TR
    Mol Ther Methods Clin Dev; 2019 Jun; 13():233-242. PubMed ID: 30828586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. rAAV-PHP.B escapes the mouse eye and causes lethality whereas rAAV9 can transduce aniridic corneal limbal stem cells without lethality.
    Mirjalili Mohanna SZ; Korecki AJ; Simpson EM
    Gene Ther; 2023 Sep; 30(9):670-684. PubMed ID: 37072572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infectivity Assessment of Recombinant Adeno-Associated Virus and Wild-Type Adeno-Associated Virus Exposed to Various Diluents and Environmental Conditions.
    Tomono T; Hirai Y; Chono H; Mineno J; Ishii A; Onodera M; Tamaoka A; Okada T
    Hum Gene Ther Methods; 2019 Aug; 30(4):137-143. PubMed ID: 31317781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postsurgical assessment and long-term safety of recombinant adeno-associated virus-mediated gene transfer into the retinas of dogs and primates.
    Le Meur G; Weber M; Péréon Y; Mendes-Madeira A; Nivard D; Deschamps JY; Moullier P; Rolling F
    Arch Ophthalmol; 2005 Apr; 123(4):500-6. PubMed ID: 15824224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy.
    Liu J; Saghizadeh M; Tuli SS; Kramerov AA; Lewin AS; Bloom DC; Hauswirth WW; Castro MG; Schultz GS; Ljubimov AV
    Mol Vis; 2008; 14():2087-96. PubMed ID: 19023450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
    Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S
    Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. rAAV9 combined with renal vein injection is optimal for kidney-targeted gene delivery: conclusion of a comparative study.
    Rocca CJ; Ur SN; Harrison F; Cherqui S
    Gene Ther; 2014 Jun; 21(6):618-28. PubMed ID: 24784447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Serum rAAV Serotype-Specific Antibodies in Patients with Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Inclusion Body Myositis, or GNE Myopathy.
    Zygmunt DA; Crowe KE; Flanigan KM; Martin PT
    Hum Gene Ther; 2017 Sep; 28(9):737-746. PubMed ID: 28042944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors.
    Lu Y; Song S
    Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17158-62. PubMed ID: 19805176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary human cells differ in their susceptibility to rAAV-2-mediated gene transfer and duration of reporter gene expression.
    Rohr UP; Kronenwett R; Grimm D; Kleinschmidt J; Haas R
    J Virol Methods; 2002 Sep; 105(2):265-75. PubMed ID: 12270659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal specificity of alpha-synuclein toxicity and effect of Parkin co-expression in primates.
    Yasuda T; Miyachi S; Kitagawa R; Wada K; Nihira T; Ren YR; Hirai Y; Ageyama N; Terao K; Shimada T; Takada M; Mizuno Y; Mochizuki H
    Neuroscience; 2007 Jan; 144(2):743-53. PubMed ID: 17101231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recombinant adeno-associated virus conducted NgR(DN) enhances axonal regeneration of optic nerve after trauma: experiment with rats].
    Wang F; Wang JQ; Su Y; Shan YC; Zhao SG; Teng Y
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2856-60. PubMed ID: 18167294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transduction Profile of the Marmoset Central Nervous System Using Adeno-Associated Virus Serotype 9 Vectors.
    Matsuzaki Y; Konno A; Mukai R; Honda F; Hirato M; Yoshimoto Y; Hirai H
    Mol Neurobiol; 2017 Apr; 54(3):1745-1758. PubMed ID: 26884266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus.
    Noe F; Vaghi V; Balducci C; Fitzsimons H; Bland R; Zardoni D; Sperk G; Carli M; During MJ; Vezzani A
    Gene Ther; 2010 May; 17(5):643-52. PubMed ID: 20220782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain.
    Matsuzaki Y; Konno A; Mochizuki R; Shinohara Y; Nitta K; Okada Y; Hirai H
    Neurosci Lett; 2018 Feb; 665():182-188. PubMed ID: 29175632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection.
    McLean JR; Smith GA; Rocha EM; Hayes MA; Beagan JA; Hallett PJ; Isacson O
    Neurosci Lett; 2014 Jul; 576():73-8. PubMed ID: 24882721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8.
    Inagaki K; Fuess S; Storm TA; Gibson GA; Mctiernan CF; Kay MA; Nakai H
    Mol Ther; 2006 Jul; 14(1):45-53. PubMed ID: 16713360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis.
    Ulrich-Vinther M; Carmody EE; Goater JJ; S balle K; O'Keefe RJ; Schwarz EM
    J Bone Joint Surg Am; 2002 Aug; 84(8):1405-12. PubMed ID: 12177271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilizing minimally purified secreted rAAV for rapid and cost-effective manipulation of gene expression in the CNS.
    Goodwin MS; Croft CL; Futch HS; Ryu D; Ceballos-Diaz C; Liu X; Paterno G; Mejia C; Deng D; Menezes K; Londono L; Arjona K; Parianos M; Truong V; Rostonics E; Hernandez A; Boye SL; Boye SE; Levites Y; Cruz PE; Golde TE
    Mol Neurodegener; 2020 Mar; 15(1):15. PubMed ID: 32122372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intra-ventricular infusion of rAAV1-EGFP resulted in transduction in multiple regions of adult rat brain: a comparative study with rAAV2 and rAAV5 vectors.
    Li SF; Wang RZ; Meng QH; Li GL; Hu GJ; Dou WC; Li ZJ; Zhang ZX
    Brain Res; 2006 Nov; 1122(1):1-9. PubMed ID: 17045577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.